The article entitled “N,N-Dimethyltryptamine [DMT] attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain” by Szabo et al. published recently in Neuropharmacology [1] is the last one in the series of studies on the potential benefits of DMT administration in different clinical forms of ischemia-reperfusion injury (IRI).
No takes yet. Share an insight, caveat, or question.
Frecska et al. (2021) studied this question.
Synapse has enriched 3 related papers. Consider them for comparative context: